-+ 0.00%
-+ 0.00%
-+ 0.00%

BAUSCH + LOMB: DUAL-ACTION EYE DROP STUDY FAILS PRIMARY ENDPOINT VS LIFITEGRAST ALONE AT DAY 29

Reuters·08/24/2026 20:30:00

Please log in to view news